Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant-Reference-Cited by-同舟云学术

Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant

Published:2020-10-13 Issue:1 Volume:106 Page:32-39
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur. J. Haematol.

Author:

Alblooshi Rehab¹,Kanfar Solaf¹,Lord Bridgette¹,Atenafu Eshetu G.²,Michelis Fotios V.¹^ORCID,Pasic Ivan¹^ORCID,Gerbitz Armin¹,Al‐Shaibani Zeyad¹,Viswabandya Auro¹,Kim Dennis (Dong Hwan)¹,Lam Wilson¹,Law Arjun¹,Mattsson Jonas¹,Kumar Rajat¹,Lipton Jeffrey H.¹^ORCID

Affiliation:

1. Allogeneic Blood and Marrow Transplant Program Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University Health Network Toronto ON Canada

2. Department of Biostatistics Princess Margaret Cancer Centre University Health Network Toronto ON Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13482

Reference34 articles.

1. Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training

2. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease

3. Predictors of Late Cardiovascular Complications in Survivors of Hematopoietic Cell Transplantation

4. Cardiovascular disease in survivors of hematopoietic cell transplantation

5. Risk factors of cardiovascular disease after hematopoietic cell transplantation;Armenian S;Clin Adv Hematol Oncol,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults;JACC: CardioOncology;2024-08

2. Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation;Current Treatment Options in Oncology;2024-07-25

3. Risk factors and survival outcomes in children with early cardiotoxicity after allogeneic hematopoietic stem cell transplantation;Annals of Hematology;2024-05-06

4. Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association;Circulation;2024-04-16

5. Pre-HSCT Cardiovascular Evaluation;Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation;2024